The American online pharmacy Hims & Hers has publicly reacted to a lawsuit filed by the Danish pharmaceutical giant Novo Nordisk, claiming patent infringement. In a post on social media platform X, Hims & Hers labeled the lawsuit as an "obvious attack from a Danish company on millions of Americans". This statement comes after their recent attempt to market a pill form of Wegovy, a weight-loss drug, which they were forced to halt shortly after launch due to regulatory concerns regarding its approval status from American authorities.

Last week, Hims & Hers launched a copy of Wegovy in pill form, although they had to cease sales after just a few days. Novo Nordisk had previously threatened legal action over their product, and the lawsuit is a continuation of that threat. The company has now reiterated that this legal action is part of a broader trend where big pharmaceutical companies utilize the American legal system to restrict consumer choices.

This situation highlights the ongoing tension between generic drug manufacturers and established pharmaceutical companies, particularly in the U.S., where patent protection is a contentious issue. Hims & Hers’ stance portrays them as advocates for consumer rights against the perceived monopoly of major drug companies, raising implications for pharmaceutical competition and innovation in the American market.